Nebulized Versus Intravenous Dexmedetomidine for Sevoflurane Induced Emergence Agitation After Pediatric Tonsillectomy
Emergence Agitation
About this trial
This is an interventional prevention trial for Emergence Agitation
Eligibility Criteria
Inclusion Criteria: ASA I and II Children scheduled for tonsillectomy with or without adenoidectomy with or without myringotomy, and/or tympanostomy tube insertion. Exclusion Criteria: Patient's guardian refusal to participate in the study. Children with Behavioral changes; physical or developmental delay; neurological disorder or psychological disorder. Children on sedative or anticonvulsant medication. history of sleep apnea significant organ dysfunction, cardiac dysrhythmia, congenital heart disease Known allergy to the study drugs.
Sites / Locations
- Assiut UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Nebulized Dexmedetomidine
Intravenous Dexmedetomidine
Children will receive a nebulized dexmedetomidine 2 mic/ kg diluted in 3 ml of 0.9% saline 1 h before induction of anaesthesia.
Children will receive intravenous (IV) dexmedetomidine 1mic/kg diluted in 10 ml of 0.9% saline over 10 minutes after anesthesia induction.